Prozac Documents Deemed "Missing" Were Already Available, Lilly Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The documents which appeared in the British Medical Journal were shared with FDA, published in medical journals or produced through legal discovery over 10 years ago, Lilly says. The company maintains the medical journal "published data without validating the information."
You may also be interested in...
Lilly Launches PR Blitz On Prozac To Dispute Journal's Safety Claims
Full-page ad in major newspapers defends Lilly's handling of "missing" Prozac safety data and urges patients not to discontinue use of antidepressant based solely on media reports. Company also questions British Medical Journal's use of adverse event reports to draw conclusions about fluoxetine's safety profile.
Lilly Launches PR Blitz On Prozac To Dispute Journal's Safety Claims
Full-page ad in major newspapers defends Lilly's handling of "missing" Prozac safety data and urges patients not to discontinue use of antidepressant based solely on media reports. Company also questions British Medical Journal's use of adverse event reports to draw conclusions about fluoxetine's safety profile.
Michael Moore Gives Sicko New Life
Filmmaker has heightened his focus on a documentary looking at the American health care system, including the drug industry. Handicapping of Fahrenheit 9/11's chances in the Oscar race appears to be one factor behind renewing work on the project.